← All organizations

ImmunoVaccine Technologies, Inc.

For profitWebsite ↗

Also known as: ImmunoVaccine Technologies, Inc. (IMV Inc.)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 5, 2022

Timeline

2000s

Jun 1, 2000
ImmunoVaccine Technologies, Inc.— Founded

Drugs by trial phase (7 distinct, 11 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT05243524Lead sponsorPhase 2Aug 5, 2022
NCT04920617Lead sponsorPhase 2Jun 18, 2021
NCT03836352Lead sponsorPhase 2Dec 21, 2018
NCT03349450CollaboratorPhase 2Mar 13, 2018
NCT03029403CollaboratorPhase 2Mar 13, 2017
NCT02785250Lead sponsorPhase 1Apr 1, 2016
NCT02472548CollaboratorPhase 1May 1, 2015
NCT02323230Lead sponsorPhase 2Jan 1, 2015
NCT03332576Lead sponsorPhase 1Aug 23, 2013
NCT01416038Lead sponsorPhase 1Dec 1, 2011
NCT01095848Lead sponsorPhase 1Mar 1, 2010

Details

Founded: Halifax, CA Jun 1, 2000
Last known activity: Aug 5, 2022